These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10916847)

  • 1. [A pleurisy that can speak of her].
    Bulckaen H; Fauchais AL; Michon-Pasturel U; Queyrel V; Hachulla E; Hatron PY; Devulder B
    Rev Med Interne; 2000 Jun; 21 Suppl 3():333s-335s. PubMed ID: 10916847
    [No Abstract]   [Full Text] [Related]  

  • 2. Suggestive evidence for bromocriptine-induced pleurisy.
    Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ
    Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.
    Anglès A; Bagheri H; Saivin S; Montastruc JL
    Therapie; 2002; 57(4):408-10. PubMed ID: 12422563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
    Goetz CG; Tanner CM; Glantz RH; Klawans HL
    Neurology; 1985 May; 35(5):749-51. PubMed ID: 3990974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C; Mairesse M; Lenclud C; Gevenois PA; De Vuyst P
    Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep attacks and Parkinson's disease treatment.
    Ferreira JJ; Galitzky M; Montastruc JL; Rascol O
    Lancet; 2000 Apr; 355(9212):1333-4. PubMed ID: 10776750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzer workshop on the treatment of Parkinson's disease.
    Mizuno Y; Yanagisawa N
    Eur Neurol; 1997; 38 Suppl 1():44-57. PubMed ID: 9276201
    [No Abstract]   [Full Text] [Related]  

  • 9. Developments in the treatment of parkinsonism.
    Calne DB
    N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Pullan PT
    Intern Med J; 2009 Apr; 39(4):213-5. PubMed ID: 19402858
    [No Abstract]   [Full Text] [Related]  

  • 11. [Revision of the treatment strategy in Parkinson disease].
    Staal-Schreinemachers AL; Wesseling H; Lakke JP
    Ned Tijdschr Geneeskd; 1986 May; 130(20):914-8. PubMed ID: 3724865
    [No Abstract]   [Full Text] [Related]  

  • 12. Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
    Comet R; Domingo C; Such JJ; Ribera G; Sans J; Marín A
    Respir Med; 1998 Sep; 92(9):1172-4. PubMed ID: 9926176
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I; Gawel MJ; Riopelle RJ; Bouchard S
    Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P; Simon F; Vaylet F; Renard JL; L'Her P
    Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
    Ludin HP
    Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(3):161-6. PubMed ID: 2868512
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and future approaches to therapy.
    Birkmayer W; Birkmayer JD
    Adv Neurol; 1987; 45():511-2. PubMed ID: 3103393
    [No Abstract]   [Full Text] [Related]  

  • 18. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
    Sampaio C; Coelho T; Castro-Caldas A; Bastos-Lima A; Levy A
    J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
    Champagne S; Coste E; Peyrière H; Nigond J; Mania E; Pons M; Hillaire-Buys D; Balmes P; Blayac JP; Davy JM
    Ann Pharmacother; 1999 Oct; 33(10):1050-4. PubMed ID: 10534217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.